Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02694965 · ClinicalTrials.gov registry record
Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 122
- Enrollment target
NCT02694965 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 122 participants.
The verdict
NCT02694965 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
Purpose of the study: The investigators are proposing that melanomas which respond and develop eventual disease stability in response to checkpoint inhibitor immunotherapy undergo a genetic program promoting secondary resistance.
Interventions
- OTHER observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2016-01 |
| Est. Completion | 2023-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02694965
The ClinicalTrials.gov registry entry for NCT02694965 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observational is the first listed.
NCT02694965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02694965 about?
NCT02694965 is a clinical study titled "Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma". Purpose of the study: The investigators are proposing that melanomas which respond and develop eventual disease stability in response to checkpoint inhibitor immunotherapy undergo a genetic program promoting secondary resistance.
What is the current status of trial NCT02694965?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2016-01. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT02694965?
The interventions under investigation include: observational (OTHER).
Who is sponsoring clinical trial NCT02694965?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.